“…If there is no transfer by GlcNAc-TII thereafter to the α1,6-mannose, then the glycan remains in a hybrid state (i.e., sharing aspects of oligomannosidic and complex structures); also even if GlcNAc-TIV (β1,4-specific) modifies the α1,3-mannose, then the glycan is still classified as being hybrid (Kornfeld & Kornfeld, 1985). The lower arm β1,2- and β1,4-GlcNAc residues on hybrid glycans can be modified in different ways; elongation by β1,4- N- acetylgalactosamine and β1,3- or β1,4-galactose are known in insects, molluscs, nematodes and trematodes, whether these be host or parasitic organisms (Kurz et al , 2015; Kurz et al , 2013; Martini et al , 2019; Nyame et al , 1989; Smit et al , 2015). If however, GlcNAc-TII acts and then the ‘lower’ arm β1,2-GlcNAc transferred by GlcNAc-TI is removed by a Golgi hexosaminidase such as fdl (fused lobes) in insects or HEX-2 in nematodes (Geisler & Jarvis, 2012; Gutternigg et al , 2007b), then the resulting glycans can be referred to as ‘pseudohybrid’.…”